Stock Market News for May 8, 2026
448 news published.
Biotech regulatory moves that could sway sectors
Biogen (BIIB) and Eisai (B) updated the FDA priority review timetable for LEQEMBI® IQLIK™, setting a PDUFA date of Aug. 24 that will guide reimbursement, launch sequencing and pricing expectations across neuroscience names.
argenx (ARGX) won a material U.S. FDA approval expanding VYVGART and VYVGART Hytrulo for all adult patients living with gMG, a commercial expansion that could accelerate revenue and broaden patient access for the neuromuscular franchise.
Longeveron (LGVN) told investors it had a constructive Type C meeting with the FDA ahead of an ELPIS II Phase 2b readout—an interaction that can meaningfully de‑risk timing and regulatory clarity if the data are favorable.
Caris Life Sciences (CAI) submitted an application to the New York State Department of Health for Caris Assure blood‑based testing authorization, a market‑access step that could accelerate clinical adoption and reimbursement conversations for its diagnostics offering.
Moleculin Biotech (MBRX) added a patent that bolsters exclusivity around annamycin, strengthening IP ahead of partnering conversations; see the patent notice.
Alpha Tau (DRTS) completed enrollment in its U.S. pivotal skin‑cancer trial for Alpha DaRT®, moving the program closer to a potential FDA filing and a meaningful de‑risking inflection if topline results are positive; read the update.
Earnings roundup: select beats, guidance lifts and financials
- Brookfield Asset Management (BAM) reported strong Q1 results, reinforcing cash‑generation themes for alternative managers.
- Enbridge (ENB) posted robust Q1 results and reaffirmed 2026 guidance with a secured backlog of $40 billion.
- Plains All American (PAA) raised 2026 guidance after Q1, signaling midstream resiliency.
- PPL (PPL) delivered solid Q1 earnings and reaffirmed targets, supporting utility allocations for income investors.
- Entera (ENTX) reported first‑quarter 2026 results and provided program updates on oral peptides—data and cash runway notes that biotech investors will parse.
- Femasys (FEMY) released Q1 financials and a corporate update, helpful for near‑term visibility on commercialization efforts.
- Janus Henderson Group (JHG) reported first‑quarter 2026 results, useful for assessing flows and fee trends across active management strategies.
Capital markets: buybacks, raises, convertibles and governance signals
Tempus (TEM) priced an upsized $400 million convertible, shoring up liquidity while introducing conversion‑related dilution risk. Artiva (ARTV)'s $300 million offering forces a financing vs. pipeline trade‑off.
NVR (NVR) authorized a share repurchase program, a capital return move that supports per‑share metrics and may signal confidence in cash generation for the homebuilder.
Array Digital Infrastructure (AD) formed a special committee after a proposal from TDS (TDS), keeping takeover dynamics active. Con Edison (ED) announced a $2 billion at‑the‑market equity program, which could ease funding for grid projects but weighs on near‑term supply.
Semiconductors, defense and manufacturing strategy
SkyWater Technology (SKYT) stockholders approved a merger agreement with IonQ, clearing a shareholder hurdle for a deal that blends foundry capacity with quantum exposure—watch integration risks and roadmap shifts for chip supply chains.
MDA Space (MDA) inaugurated a high‑volume satellite manufacturing facility in Montréal, a capacity expansion that could lower per‑unit costs and make commercial constellations more scalable; read the facility announcement.
Tenaris (TS) agreed to acquire Artrom Steel Tubes S.A.'s seamless pipe plant in Romania in a deal that expands manufacturing footprint in Europe and could improve supply chain flexibility for tubulars used in energy infrastructure; see the transaction notice.
Battery and materials traction continued: J‑Star Holding (YMAT) signed an MOU on financing for a Texas solid‑state battery facility, while E‑Power (EPOW) was granted a landmark patent, accelerating sodium‑ion commercialization prospects.
AI, digital money and institutional crypto engagement
Exodus (EXOD) launched XO Cash, targeting machine‑to‑machine payments as AI agents scale transaction volumes. DocuSign (DOCU) partnered with Harvey to bring legal and contract AI together, a move that could speed contract review automation; details are in their partnership release.
M&A, take‑privates and corporate actions
European Wax Center (EWCZ) completed a take‑private by General Atlantic, removing a franchisor from public markets and reshaping exit expectations; read the close notice. Two (TWO) and CrossCountry Mortgage amended terms to raise all‑cash consideration to $12.00, tightening arbitrage spreads for deal investors; see the merger update.
Selected corporate results, going‑concern and operational shifts
- Koppers (KOP) reported Q1 results and announced a conditional plan to wind down production at its Stickney, Illinois facility—an operational pivot that could affect near‑term volumes; see the Q1 release and the facility notice.
- TOMI Environmental Solutions (TOMZ) reported Q1 2026 results and announced a letter of intent to merge with Carbonium Core, a deal that could reshape its technology mix and scale.
- DSS, Inc. (DSS) disclosed a going‑concern audit opinion in its 2025 10‑K filing, an accounting flag that raises liquidity and solvency questions for investors to monitor closely.
- Gencor (GENC) released Q2 fiscal 2026 results that investors will use to assess cyclicality in their business mix; read the results.
- Douglas Elliman (DOUG) reported first‑quarter 2026 financial results, a read on high‑end real‑estate brokerage trends and transaction volumes.
- Trump Media & Technology Group (DJT) released Q1 results; while profile keeps attention high, investors will focus on advertising and user‑metrics for monetization signals.
Defense & security wins and conference showcases
Draganfly (DPRO) said its Flex FPV drone was selected by two additional U.S. Department of War units, an operational win that can accelerate defense revenue visibility; see their release.
Financial infrastructure, listings, ETFs and market debuts
Hexis Capital launched the Hexis Active Nicotine Engagement ETF (NICO), tapping niche thematic demand. Boost Run (BRUN) completed its business combination with Willow Lane and was approved to list on Nasdaq, a fresh public listing that brings another consumer‑facing name to market. FormFactor (FORM) will ring the Nasdaq closing bell on May 11, a visible moment for the test‑and‑measurement supplier.
Smaller headlines worth noting
- Cryo-Cell (CCEL) received acceptance of a compliance plan from NYSE American, removing near‑term listing uncertainty.
- Kandi (KNDI) announced receipt of a Nasdaq notice on minimum bid price compliance, a reminder of short‑term remediation risk for smaller caps.
- ParaZero (PRZO) also received a Nasdaq minimum bid price notification, underscoring microcap volatility themes.
- Amaze Holdings (AMZE) commented on unusual market activity, a routine investor relations response to monitor for follow‑on disclosures.
- Digi Power X (DGXX) upsized its at‑the‑market offering program, a liquidity step that could add supply pressure for small‑cap holders.
- Network 1 (NTIP) reported first‑quarter 2026 results, a routine update for investors tracking cybersecurity finance vehicles.
- Austin Gold (AUST) posted its 2025 annual disclosure documents.
- FormFactor (FORM) will ring the Nasdaq closing bell on May 11; a ceremonial event rather than a material corporate development.
- Canadian Natural Resources (CNQ) and Gran Tierra Energy (GTE) reported final voting results and annual meeting outcomes, housekeeping items that confirm board and governance paths.
What investors should watch next
Key market movers include the Aug. 24 PDUFA on Leqembi/Iqlik and any FDA communications; argenx's expanded VYVGART label and what that means for neuromuscular revenue trajectories; Tenaris' Romania acquisition and SkyWater/IonQ integration for manufacturing and supply chains; capital moves such as NVR's repurchase authorization and Tempus' convertible that affect share supply and dilution; and going‑concern flags like DSS's 10‑K opinion, which raise liquidity and credit monitoring priorities. Keep an eye on Nasdaq/NYSE compliance notices for microcap volatility and newly listed names for liquidity shifts.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement